Gains and Losses of HLA Class II (DR) and CD4 in Atypical Hyperplasia, Carcinoma in situ and Infiltrating Ductal Carcinoma of the Breast

Aim: Breast cancer is a frequent cause of death among women with gynaecologic malignancies despite the introduction of combination chemotherapy. There is therefore a need for new therapeutic strategies for patients with breast cancer, such as cellular immunotherapy. In this immunohistochemical study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Demetrio Tamiolakis, Ioannis Venizelos, Maria Lambropoulou, Theodoros Jivannakis, Evagelia Seliniotaki, Panagiotis Tsikouras, Vasilios Limberis, Angelos Tsalkidis, Nikolas Papadopoulos
Formato: Artigo
Idioma:Inglês
Publicado em: Karolinum Press 2004-01-01
Colecção:Acta Medica
Assuntos:
HLA class II (DR)
CD4
Atypical ductal hyperplasia of the breast
Breast cancer
Acesso em linha:https://actamedica.lfhk.cuni.cz/online_first/18059694.2018.101/
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados